Waiting For FDA: Federal Courts Debate Stays Of 'Natural' Class Actions

Mayer Brown attorney Dale Giali discusses the "natural" litigation landscape, where litigants increasingly are sparring over the appropriateness of stays in light of FDA's comment-gathering initiative launched in 2015.

Gavel

More from Legal

More from Policy & Regulation